Arix Bioscience plc

LSE:ARIX Stock Report

Market Cap: UK£176.5m

Arix Bioscience Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:ARIX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Nov 23BuyUK£46,000Peregrine David Euan MoncreiffeIndividual40,000UK£1.15
02 Nov 23BuyUK£68,814Peregrine David Euan MoncreiffeIndividual60,000UK£1.15
04 May 23BuyUK£115,043Robert LyneIndividual107,657UK£1.07
04 May 23SellUK£89,344Robert LyneIndividual85,419UK£1.05
27 Apr 23BuyUK£76,875Peregrine David Euan MoncreiffeIndividual75,000UK£1.03
27 Apr 23BuyUK£24,999Robert LyneIndividual24,330UK£1.03

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ARIX?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme1,294,3281.04%
Public Companies5,751,1154.63%
Individual Insiders7,799,0976.27%
Private Companies13,996,54811.3%
General Public14,152,03411.4%
Hedge Funds33,023,21026.6%
Institutions48,292,59438.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 79% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
26.6%
RTW Investments, LP
33,023,210UK£46.9m0%0.94%
9.1%
Fosun International Holdings Ltd.
11,309,849UK£16.1m0%no data
5.5%
Christopher Chipperton
6,832,889UK£9.7m0%no data
4.54%
UCB SA
5,647,679UK£8.0m0%no data
3.72%
Castellain Capital LLP
4,619,772UK£6.6m0%18.89%
2.31%
Border To Coast Pensions Partnership Limited
2,876,716UK£4.1m-14.8%0.06%
2.27%
Brewin Dolphin Limited
2,818,308UK£4.0m0.27%0.03%
2.16%
Ectoplasm Ltd
2,686,699UK£3.8m0%no data
2.12%
Societe Generale Group, Banking Investments
2,640,000UK£3.7m0%0.03%
2.06%
Heartwood Wealth Management, Asset Management Arm
2,564,994UK£3.6m0%0.29%
1.95%
Rathbones Investment Management Limited
2,421,402UK£3.4m-1.53%0.01%
1.93%
BNP Paribas, Private & Investment Banking Investments
2,400,000UK£3.4m0%0.03%
1.75%
Aspiriant, LLC
2,172,142UK£3.1m0%0.15%
1.69%
Tetragon Financial Management LP
2,100,000UK£3.0m0%6.53%
1.43%
A J Bell Holdings Limited, Asset Management Arm
1,779,197UK£2.5m-0.73%0.03%
1.4%
Charles Stanley & Co. Ltd, Asset Management Arm
1,744,094UK£2.5m1.5%0.03%
1.27%
Amundi Asset Management SAS
1,579,953UK£2.2m587%no data
1.21%
Nomura Holdings Inc, Securities & Investment Arm
1,500,000UK£2.1m0%0.02%
1.18%
Evelyn Partners Investment Management LLP
1,465,846UK£2.1m-0.97%0.03%
1.18%
Brooks MacDonald Asset Management
1,465,000UK£2.1m0%0.2%
1.04%
The Arix Bioscience Plc Employee Benefit Trust
1,294,328UK£1.8m0%no data
0.76%
UBS Asset Management AG
949,482UK£1.3m1.39%no data
0.63%
Mole Valley Asset Management Ltd
783,619UK£1.1m1.15%4.66%
0.62%
Morgan Stanley, Investment Banking and Brokerage Investments
775,000UK£1.1m11.4%no data
0.6%
Carvetian Capital Management Limited
750,000UK£1.1m0%25.93%
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.